J. Ritter

1.6k total citations
39 papers, 1.1k citations indexed

About

J. Ritter is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, J. Ritter has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Molecular Biology. Recurrent topics in J. Ritter's work include Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (8 papers) and Sarcoma Diagnosis and Treatment (5 papers). J. Ritter is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (8 papers) and Sarcoma Diagnosis and Treatment (5 papers). J. Ritter collaborates with scholars based in Germany, United States and Austria. J. Ritter's co-authors include Ursula Creutzig, Helmut Gadner, Dirk Reinhardt, Georg Mann, Andreas H. Groll, H. Jürgens, Maurizio Aricò, Stephan Ladisch, Nicole Grois and Ulrike Pötschger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

J. Ritter

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Ritter Germany 19 388 262 255 218 193 39 1.1k
C. Vermylen Belgium 18 741 1.9× 168 0.6× 181 0.7× 190 0.9× 74 0.4× 56 1.4k
Hideki Nakayama Japan 18 501 1.3× 87 0.3× 310 1.2× 175 0.8× 233 1.2× 68 1.1k
Adina Cioc United States 15 276 0.7× 121 0.5× 121 0.5× 126 0.6× 133 0.7× 33 793
Margit Mitterbauer Austria 25 1.1k 2.7× 154 0.6× 272 1.1× 337 1.5× 221 1.1× 67 1.7k
Karoline Ehlert Germany 19 241 0.6× 160 0.6× 157 0.6× 241 1.1× 253 1.3× 60 1.1k
Kimikazu Yakushijin Japan 19 561 1.4× 153 0.6× 129 0.5× 215 1.0× 108 0.6× 135 1.1k
Flore Sicre de Fontbrune France 22 837 2.2× 148 0.6× 137 0.5× 188 0.9× 310 1.6× 107 1.9k
Keisei Kawa‐Ha Japan 19 705 1.8× 304 1.2× 186 0.7× 183 0.8× 137 0.7× 49 1.7k
B Taillan France 15 268 0.7× 112 0.4× 109 0.4× 96 0.4× 236 1.2× 135 1.0k
A.H. Filipovich United States 23 1.2k 3.2× 243 0.9× 209 0.8× 130 0.6× 297 1.5× 47 2.0k

Countries citing papers authored by J. Ritter

Since Specialization
Citations

This map shows the geographic impact of J. Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ritter more than expected).

Fields of papers citing papers by J. Ritter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ritter. The network helps show where J. Ritter may publish in the future.

Co-authorship network of co-authors of J. Ritter

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ritter. A scholar is included among the top collaborators of J. Ritter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ritter. J. Ritter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Creutzig, Ursula, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2011). CNS irradiation in pediatric acute myleoid leukemia: Equal results by 12 or 18 Gy in studies AML‐BFM98 and 2004. Pediatric Blood & Cancer. 57(6). 986–992. 19 indexed citations
2.
Groll, Andreas H. & J. Ritter. (2005). Diagnose und Therapie von Pilzinfektionen und der Pneumozystis-Pneumonie bei Kindern und Jugendlichen mit neoplastischen Erkrankungen. Klinische Pädiatrie. 217. 37–66. 16 indexed citations
3.
Grois, Nicole, Ulrike Pötschger, Helmut Prosch, et al.. (2005). Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatric Blood & Cancer. 46(2). 228–233. 191 indexed citations
4.
Reinhardt, Dirk, J. Ritter, Claudia Langebrake, et al.. (2004). Acute Megakaryoblastic Leukemia in Children without Down’s Syndrome.. Blood. 104(11). 401–401. 3 indexed citations
5.
Lanvers, Claudia, Dirk Reinhardt, Angelika Dübbers, et al.. (2003). Pharmacology of all‐trans‐retinoic acid in children with acute promyelocytic leukemia. Medical and Pediatric Oncology. 40(5). 293–301. 20 indexed citations
6.
Klein, Gisela, J. Michaelis, Claudia Spix, et al.. (2003). Second malignant neoplasms after treatment of childhood cancer. European Journal of Cancer. 39(6). 808–817. 46 indexed citations
7.
Groll, Andreas H., et al.. (2001). Prävention von Pilzinfektionen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen. Klinische Pädiatrie. 213(S1). A50–A68. 10 indexed citations
8.
Mann, Georg, Dirk Reinhardt, J. Ritter, et al.. (2001). Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Annals of Hematology. 80(7). 417–422. 67 indexed citations
9.
Groll, Andreas H., et al.. (2001). Empfehlungen zur Prävention der Pneumocystis-carinii-Pneumonie bei Kindern und Jugendlichen mit neoplastischen Erkrankungen. Klinische Pädiatrie. 213(S1). A38–A49. 18 indexed citations
10.
Buchheidt, Dieter, Corinna Baust, Heyko Skladny, et al.. (2001). Detection ofAspergillusSpecies in Blood and Bronchoalveolar Lavage Samples from Immunocompromised Patients by Means of 2‐Step Polymerase Chain Reaction: Clinical Results. Clinical Infectious Diseases. 33(4). 428–435. 117 indexed citations
11.
Reinhardt, Dirk, Arnulf Pekrun, M. Lakomek, et al.. (2000). Primary myelosarcomas are associated with a high rate of relapse: report on 34 children from the acute myeloid leukaemia–Berlin–Frankfurt–Münster studies. British Journal of Haematology. 110(4). 863–866. 18 indexed citations
12.
Häberle, Johannes, Beate E. Kehrel, J. Ritter, et al.. (1999). New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review. European Journal of Pediatrics. 158(11). 883–887. 20 indexed citations
13.
Stahnke, Karsten, Joachim Boos, Christine Bender‐Götze, et al.. (1998). Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia. Leukemia. 12(10). 1534–1538. 55 indexed citations
14.
Schellong, G., Marianne Riepenhausen, Ursula Creutzig, et al.. (1997). Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.. Journal of Clinical Oncology. 15(6). 2247–2253. 56 indexed citations
15.
Slavc, Irene, C. Urban, J. Ritter, et al.. (1992). Paraparesis secondary to a spinal mass as the presenting feature of erythroleukaemia in a 10-month-old child. European Journal of Pediatrics. 151(5). 332–335. 3 indexed citations
16.
17.
Kuse, R., Rüdiger Hoffmann, Doris R. Seeger, et al.. (1988). Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML). Annals of Hematology. 56(1). 19–26. 29 indexed citations
18.
Cockcroft, John R., J. Ritter, D J Allison, Roger C. Causon, & M J Brown. (1987). Location of extra-adrenal catecholamine secreting tumours by selective venous sampling and nuclear magnetic resonance scanning. Postgraduate Medical Journal. 63(740). 451–453. 1 indexed citations
19.
20.
Ritter, J., et al.. (1978). [Acute myelogenous leukemia 11 years after successful treatment of Hodgkin's disease. A contribution to the problem of secondary tumors].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 73(39). 1360–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Vermylen Breakdown of academic impact, for papers by Hideki Nakayama Breakdown of academic impact, for papers by Adina Cioc Breakdown of academic impact, for papers by Margit Mitterbauer Breakdown of academic impact, for papers by Karoline Ehlert Breakdown of academic impact, for papers by Kimikazu Yakushijin Breakdown of academic impact, for papers by Flore Sicre de Fontbrune Breakdown of academic impact, for papers by Keisei Kawa‐Ha Breakdown of academic impact, for papers by B Taillan Breakdown of academic impact, for papers by A.H. Filipovich
Rankless by CCL
2026